The Bid & Ask

Quotations, Dispatches, and the Daily Tape

Thursday, August 13, 2026

Subject of the day

NVST

Concerning the House

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products, as well as provides DTX Studio Clinic, a software package offered with its imaging products. This segment offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.

United States · envistaco.com

The Long Run

FY 2019–2025 · 7 years

LineLatestCAGRTrend
Revenue$2.72B+26.2%
Gross profit$1.44B+22.6%
Operating income-$1.04B-35.3%
Net income-$1.12B+2.2%
Cash from ops$336.50M-1.1%
Quotation

$28.08

-0.63 (-2.2%)

52w hi$30.26
52w lo$18.95
Vol2.17M
As ofAug 13
The Verdict

Hold

Our score +0.12

Short-0.10
Medium+0.23
Long+0.35

computed 2026-08-13

By the Numbers

Envista Holdings Corporation

Healthcare · Medical Instruments & Supplies

Market cap$4.51B
Enterprise value$5.07B
Trailing P/E48.41x
Forward P/E16.90x
EV / EBITDA12.12x
P / S (ttm)1.58x
Profit margin3.3%
Return on equity3.1%
Revenue growth+7.1%
Earnings growth+111.3%
Debt / equity51.62
Risk Metrics
Beta vs SPX1.28
Corr SPX0.51
Annual vol40.8%
Annual ret+36.2%
Sharpe0.89
Max DD-33.9%

Window: 504 trading days (504 obs)

Layer Breakdown
LayerRawContribution
Fundamental+0.26
Sector+0.12
Technical+0.00
Earnings+0.00
Sentiment+0.00

macro × 1.00 · 2026-08-13

Recent Sessions
DateOpenHighLowCloseVol
Aug 13$28.90$28.99$27.87$28.082.17M
Aug 12$28.26$28.90$28.01$28.712.53M
Aug 11$28.12$28.99$27.912.28M
Aug 10$27.76$28.36$27.60$28.193.07M
Aug 7$27.60$28.53$27.40$28.154.07M